MedTech Alliance 2
Singaporeedis.sg
Overview
MedTech Alliance 2 (MTA 2) is a Singapore-based accelerator and fund that invests in promising deep-tech startups at the seed and early stages. Its investment focus is on Advanced Manufacturing & Engineering and Health & Biomedical Sciences. It was established in 2018 as a consortium comprising Economic Development Innovations Singapore (EDIS), Accuron MedTech Group, and Lu Yoh-Chie, the founder of Biosensors International. MTA 2 was appointed as a co-investment partner by SPRING SEEDS Capital (the investment arm of the Singaporean government's enterprise agency) under the Startup SG Equity initiative.
Portfolio Companies
1
Website
edis.sgInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| twoplus fertility | May 2022 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.